NCT07474792Phase 2Active not recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Study sponsor: Oruka Therapeutics, Inc. · ORKA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-10Estimated
Enrollment · participants160Estimated
Source updated2026-10-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source